AN

Abhishek Nalin Sharma

Active Director Director DIN 07222246
DIN 07222246 First appointment Jul 2015 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 9 active board seats
Past companies 1 historical roles
Total affiliations 10 Since Jul 2015
Shareholding value •••• Premium profile

About Abhishek Nalin Sharma

Data last updated:

Abhishek Nalin Sharma is a Director at Wohlstand Equity Limited (since 2015), Director at Astrova Pharmaceuticals Private Limited (since 2020) and Designated Partner at Mesa Lifespaces Llp (since 2026), and holds 6 more current directorships. The companies operate in Financial Services, Pharma and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹2.14 Cr; the largest is Wohlstand Equity Limited at ₹2.05 Cr (FY 2025). Earlier, Abhishek Nalin Sharma was a Director at Young Optimist Of Urban Township And Habitats Association (2019–2022).

DIN 07222246
Primary Designation Director
Industry Financial Services
First Appointment 15 Jul 2015
Oldest Company Age 11 yrs
Largest company Wohlstand Equity Limited · ₹2.05 Cr (FY 2025)
Combined revenue ₹2.14 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wohlstand Equity Limited U74120MH2015PLC267905
Director28 Aug 20152015₹2.05 Cr (FY 2025)Active
Director20 May 20202020₹8.5 Lakh (FY 2023)Active
Designated Partner09 Feb 20262026Active
Designated Partner01 Jul 20252024Active
Partner01 Jun 20222020Active
Designated Partner22 Jun 20212021Active
Designated Partner02 Jul 20172017Active
Designated Partner01 Oct 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jun 20192014₹91.4 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Skyline Superstructure Llp
Metricon Realty Llp
Astrova Pharmaceuticals Private Limited
Wohlstand Equity Limited
Premium access

Shareholding and investment profile for Abhishek Nalin Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Nalin Sharma

Abhishek Nalin Sharma currently holds 9 directorships: Wohlstand Equity Limited (Director, since 28 Aug 2015, revenue ₹2.05 Cr (FY 2025)); Astrova Pharmaceuticals Private Limited (Director, since 20 May 2020, revenue ₹8.5 Lakh (FY 2023)); Mesa Lifespaces Llp (Designated Partner, since 09 Feb 2026); Enriching Lives Realty Llp (Designated Partner, since 01 Jul 2025); Priyanka Regency Llp (Partner, since 01 Jun 2022); and 4 more.

Abhishek Nalin Sharma was first appointed on 15 Jul 2015 as Designated Partner at Arista Logispace Llp. The most recent appointment on record is 09 Feb 2026 at Mesa Lifespaces Llp.

The 2 current companies of Abhishek Nalin Sharma that report revenue have a combined latest revenue of ₹2.14 Cr: Wohlstand Equity Limited ₹2.05 Cr (FY 2025); Astrova Pharmaceuticals Private Limited ₹8.5 Lakh (FY 2023).

Abhishek Nalin Sharma held 1 earlier board appointment: Young Optimist Of Urban Township And Habitats Association (Director, 25 Jun 2019 to 02 Jul 2022).

The current boards of Abhishek Nalin Sharma's companies include Gaurav Sunil Mansinghani (Wohlstand Equity Limited), Nalin Shyamlal Sharma (Wohlstand Equity Limited), Neha Sunil Mansinghani (Wohlstand Equity Limited), Tejas Rajan Pol (Astrova Pharmaceuticals Private Limited), Hitesh Suresh Jain (Mesa Lifespaces Llp), Mohammed Ibrahim Shaikh (Enriching Lives Realty Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available